<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Genes considered clinically relevant for dilated cardiomyopathy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Genes considered clinically relevant for dilated cardiomyopathy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Genes considered clinically relevant for dilated cardiomyopathy</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1">Gene</td> <td class="subtitle1">Protein</td> <td class="subtitle1">OMIM</td> <td class="subtitle1">Estimated fraction of DCM</td> <td class="subtitle1">Reference*</td> </tr> <tr class="divider_top"> <td class="subtitle2_left" colspan="5">Strongest evidence<sup>¶</sup></td> </tr> <tr> <td class="indent1"><em>LMNA</em></td> <td>Lamin A/C</td> <td class="centered">150330</td> <td class="centered">0.06</td> <td class="centered">[1-14]</td> </tr> <tr> <td class="indent1"><em>MYH7</em></td> <td>Beta-myosin heavy chain</td> <td class="centered">160760</td> <td class="centered">0.04</td> <td class="centered">[15-18]</td> </tr> <tr> <td class="indent1"><em>TNNT2</em></td> <td>Cardiac troponin T</td> <td class="centered">191045</td> <td class="centered">0.03</td> <td class="centered">[15,17-23]</td> </tr> <tr class="divider_bottom"> <td class="indent1"><em>RBM20</em> (hotspot)<sup>Δ</sup></td> <td>RNA binding protein 20</td> <td class="centered">613171</td> <td class="centered">0.02</td> <td class="centered">[24,25]</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Strong evidence</td> </tr> <tr> <td class="indent1"><em>TTN</em> – truncating variants</td> <td>Titin</td> <td class="centered">188840</td> <td class="centered">0.15 to 0.20</td> <td class="centered">[26-32]</td> </tr> <tr> <td class="indent1"><em>BAG3</em></td> <td>BCL-associated athanogene 3</td> <td class="centered">603883</td> <td class="centered">0.03</td> <td class="centered">[33-35]</td> </tr> <tr> <td class="indent1"><em>SCN5A</em></td> <td>Sodium channel</td> <td class="centered">600163</td> <td class="centered">0.02</td> <td class="centered">[18,36,37]</td> </tr> <tr> <td class="indent1"><em>FLNC</em></td> <td>Filamin C</td> <td class="centered">102565</td> <td class="centered">0.02 to 0.04</td> <td class="centered">[38,39]</td> </tr> <tr> <td class="indent1"><em>TPM1</em></td> <td>Alpha-tropomyosin</td> <td class="centered">191010</td> <td class="centered">&lt;0.01</td> <td class="centered">[40-42]</td> </tr> <tr> <td class="indent1"><em>PLN</em></td> <td>Phospholamban</td> <td class="centered">172405</td> <td class="centered">&lt;0.01</td> <td class="centered">[17,43-47]</td> </tr> <tr> <td class="indent1"><em>TNNC1</em></td> <td>Cardiac troponin C</td> <td class="centered">191040</td> <td class="centered">&lt;0.01</td> <td class="centered">[21,41,48]</td> </tr> <tr> <td class="indent1"><em>TNNI3</em></td> <td>Cardiac troponin I</td> <td class="centered">191044</td> <td class="centered">&lt;0.01</td> <td class="centered">[41,49,50]</td> </tr> <tr class="divider_bottom"> <td class="indent1"><em>EYA4</em></td> <td>Eyes-absent 4</td> <td class="centered">603550</td> <td class="centered">?</td> <td class="centered">[51]</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Variable evidence</td> </tr> <tr> <td class="indent1"><em>MYPN</em></td> <td>Myopalladin</td> <td class="centered">608517</td> <td class="centered">0.03</td> <td class="centered">[52]</td> </tr> <tr> <td class="indent1"><em>MYBPC3</em></td> <td>Myosin-binding protein C</td> <td class="centered">600958</td> <td class="centered">0.02</td> <td class="centered">[16,41]</td> </tr> <tr> <td class="indent1"><em>MYH6</em></td> <td>Alpha-myosin heavy chain</td> <td class="centered">160710</td> <td class="centered">0.04</td> <td class="centered">[41,53]</td> </tr> <tr> <td class="indent1"><em>LAMA4</em></td> <td>Laminin alpha-4</td> <td class="centered">600133</td> <td class="centered">&lt;0.01</td> <td class="centered">[54]</td> </tr> <tr> <td class="indent1"><em>VCL</em></td> <td>Metavinculin</td> <td class="centered">193065</td> <td class="centered">&lt;0.01</td> <td class="centered">[17,55]</td> </tr> <tr> <td class="indent1"><em>LDB3</em></td> <td>Cypher/ZASP</td> <td class="centered">605906</td> <td class="centered">&lt;0.01</td> <td class="centered">[18,56]</td> </tr> <tr> <td class="indent1"><em>TCAP</em></td> <td>Titin-cap or telethonin</td> <td class="centered">604488</td> <td class="centered">&lt;0.01</td> <td class="centered">[18,57]</td> </tr> <tr> <td class="indent1"><em>ACTN2</em></td> <td>Alpha-actinin-2</td> <td class="centered">102573</td> <td class="centered">&lt;0.01</td> <td class="centered">[58]</td> </tr> <tr> <td class="indent1"><em>CRYAB</em></td> <td>Alpha B crystalin</td> <td class="centered">123590</td> <td class="centered">&lt;0.01</td> <td class="centered">[59]</td> </tr> <tr> <td class="indent1"><em>RBM20</em> (non-hotspot)</td> <td>RNA binding protein 20</td> <td class="centered">613171</td> <td class="centered">?</td> <td class="centered">[25]</td> </tr> <tr> <td class="indent1"><em>ABCC9</em></td> <td>SUR2A</td> <td class="centered">601439</td> <td class="centered">&lt;0.01</td> <td class="centered">[60]</td> </tr> <tr> <td class="indent1"><em>ACTC1</em></td> <td>Cardiac actin</td> <td class="centered">102540</td> <td class="centered">&lt;0.01</td> <td class="centered">[61-66]</td> </tr> <tr> <td class="indent1"><em>PDLIM3</em></td> <td>PDZ LIM domain protein 3</td> <td class="centered">605889</td> <td class="centered">&lt;0.01</td> <td class="centered">[67]</td> </tr> <tr> <td class="indent1"><em>ILK</em></td> <td>Integrin-linked kinase</td> <td class="centered">602366</td> <td class="centered">&lt;0.01</td> <td class="centered">[54]</td> </tr> <tr> <td class="indent1"><em>SGCD</em></td> <td>Delta-sarcoglycan</td> <td class="centered">601411</td> <td class="centered">&lt;0.01</td> <td class="centered">[68-70]</td> </tr> <tr> <td class="indent1"><em>DES</em></td> <td>Desmin</td> <td class="centered">125660</td> <td class="centered">&lt;0.01</td> <td class="centered">[64,69,71]</td> </tr> <tr> <td class="indent1"><em>CSRP3</em></td> <td>Muscle LIM protein</td> <td class="centered">600824</td> <td class="centered">&lt;0.01</td> <td class="centered">[18,72]</td> </tr> <tr> <td class="indent1"><em>ANKRD1</em></td> <td>Ankyrin repeat domain-containing protein 1</td> <td class="centered">609599</td> <td class="centered">?</td> <td class="centered">[73,74]</td> </tr> <tr> <td class="indent1"><em>NEXN</em></td> <td>Nexilin</td> <td class="centered">613121</td> <td class="centered">?</td> <td class="centered">[75]</td> </tr> <tr class="divider_bottom"> <td class="indent1"><em>NEBL</em></td> <td>Nebulette</td> <td class="centered">605491</td> <td class="centered">?</td> <td class="centered">[76]</td> </tr> <tr> <td class="subtitle2_left" colspan="5">ARVC genes</td> </tr> <tr> <td class="indent1"><em>DSP</em></td> <td>Desmoplakin</td> <td class="centered">125660</td> <td class="centered">?</td> <td class="centered">[77-81]</td> </tr> <tr> <td class="indent1"><em>PKP2</em></td> <td>Plakophilin 2</td> <td class="centered">602861</td> <td class="centered">?</td> <td class="centered">[77-79]</td> </tr> <tr> <td class="indent1"><em>DSG2</em></td> <td>Desmoglein 2</td> <td class="centered">125671</td> <td class="centered">?</td> <td class="centered">[77-79]</td> </tr> <tr> <td class="indent1"><em>DSC2</em></td> <td>Desmocollin 2</td> <td class="centered"> 125645 </td> <td class="centered"> ? </td> <td class="centered">[82] </td> </tr> </tbody></table></div><div class="graphic_lgnd">Genes have been categorized based on strength of evidence.</div><div class="graphic_footnotes">OMIM: Online Mendelian Inheritance in Man; DCM: dilated cardiomyopathy; ARVC: arrhythmogenic right ventricular cardiomyopathy.<br/>* References not necessarily exhaustive, especially on genes with strongest or strong evidence. Syndromic genes (eg, <em>TAZ</em>, <em>DMD</em>) not included.<br/>¶ Most variants shown to be DCM disease-causing have been rare missense variants.<br/>Δ Restricted to the <em>RBM20</em> 6 amino acid hotspot.</div><div class="graphic_reference">References: 

<ol>
<li>Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999; 341:1715.</li>
<li>Brodsky G, Muntoni F, Miocic S, et al. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000; 101:473.</li>
<li>Becane HM, Bonne G, Varnous S, et al. High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol 2000; 23:1661.</li>
<li>Jakobs PM, Hanson E, Crispell KA, et al. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. J Card Fail 2001; 7:249.</li>
<li>Arbustini E, Pilotto A, Repetto A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002; 39:981.</li>
<li>Hershberger RE, Hanson E, Jakobs PM, et al. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. Am Heart J 2002; 144:1081.</li>
<li>Taylor MR, Fain PR, Sinagra G, et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003; 41:771.</li>
<li>Sebillon P, Bouchier C, Bidot LD, et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 2003; 40:560.</li>
<li>MacLeod HM, Culley MR, Huber JM, McNally EM. Lamin A/C truncation in dilated cardiomyopathy with conduction disease. BMC Med Genet 2003; 4:4.</li>
<li>Sylvius N, Bilinska ZT, Veinot JP, et al. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet 2005; 42:639.</li>
<li>Pethig K, Genschel J, Peters T, et al. LMNA mutations in cardiac transplant recipients. Cardiology 2005; 103:57.</li>
<li>Karkkainen S, Reissell E, Helio T, et al. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart 2006; 92:524.</li>
<li>Parks SB, Kushner JD, Nauman D, et al. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J 2008; 156:161.</li>
<li>Pasotti M, Klersy C, Pilotto A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 2008; 52:1250.</li>
<li>Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000; 343:1688.</li>
<li>Daehmlow S, Erdmann J, Knueppel T, et al. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun 2002; 298:116.</li>
<li>Villard E, Duboscq-Bidot L, Charron P, et al. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J 2005; 26:794.</li>
<li>Hershberger RE, Parks SB, Kushner JD, et al. Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci 2008; 1:21.</li>
<li>Hanson E, Jakobs P, Keegan H, et al. Cardiac troponin T lysine-210 deletion in a family with dilated cardiomyopathy. J Card Fail 2002; 8:28.</li>
<li>Li D, Czernuszewicz GZ, Gonzalez O, et al. Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 2001; 104:2188.</li>
<li>Mogensen J, Murphy RT, Shaw T, et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004; 44:2033.</li>
<li>Moller DV, Andersen PS, Hedley P, et al. The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet 2009; 17:1241.</li>
<li>Hershberger RE, Pinto JR, Parks SB, et al. Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circ Cardiovasc Genet 2009; 2:306.</li>
<li>Brauch KM, Karst ML, Herron KJ, et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol 2009; 54:930.</li>
<li>Li D, Morales A, Gonzalez Quintana J, et al. Identification of novel mutations In RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci 2010; 3:90.</li>
<li>Gerull B, Gramlich M, Atherton J, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002; 30:201.</li>
<li>Gerull B, Atherton J, Geupel A, et al. Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy. J Mol Med 2006; 84:478.</li>
<li>Herman DS, Lam L, Taylor MR, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012; 366:619.</li>
<li>Norton N, Li D, Rampersaud E, et al. Exome Sequencing and Genome-Wide Linkage Analysis in 17 Families Illustrates the Complex Contribution of TTN Truncating Variants to Dilated Cardiomyopathy. Circ Cardiovasc Genet 2013; 6:144.</li>
<li>Roberts AM, Ware JS, Herman DS, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med 2015; 7:270ra6.</li>
<li>Ware JS, Li J, Mazaika E, et al. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med 2016; 374:233.</li>
<li>Schafer S, de Marvao A, Adami E, et al. Titin-truncating variants affect heart function in disease cohorts and the general population. Nat Genet 2017; 49:46.</li>
<li>Norton N, Li D, Reider MJ, et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet 2011; 88:273.</li>
<li>Villard E, Perret C, Gary F, et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 2011; 32:1065.</li>
<li>Arimura T, Ishikawa T, Nunoda S, et al. Dilated cardiomyopathy-associated BAG3 mutations impair Z-disc assembly and enhance sensitivity to apoptosis in cardiomyocytes. Hum Mutat 2011; 32:1481.</li>
<li>McNair WP, Ku L, Taylor MR, et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004; 110:2163.</li>
<li>Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005; 293:447.</li>
<li>Begay RL, Tharp CA, Martin A, et al. FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy. JACC Basic Transl Sci 2016; 1:344.</li>
<li>Ortiz-Genga MF, Cuenca S, Dal Ferro M, et al. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J Am Coll Cardiol 2016; 68:2440.</li>
<li>Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001; 33:723.</li>
<li>Hershberger RE, Norton N, Morales A, et al. Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet 2010; 3:155.</li>
<li>Lakdawala NK, Dellefave L, Redwood CS, et al. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol 2010; 55:320.</li>
<li>Schmitt JP, Kamisago M, Asahi M, et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 2003; 299:1410.</li>
<li>Haghighi K, Kolokathis F, Pater L, et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 2003; 111:869.</li>
<li>DeWitt MM, MacLeod HM, Soliven B, McNally EM. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J Am Coll Cardiol 2006; 48:1396.</li>
<li>Medin M, Hermida-Prieto M, Monserrat L, et al. Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN –42 C&gt;G mutation. Eur J Heart Fail 2007; 9:37.</li>
<li>Liu GS, Morales A, Vafiadaki E, et al. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. Cardiovasc Res 2015; 107:164.</li>
<li>Pinto JR, Siegfried JD, Parvatiyar MS, et al. Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy. J Biol Chem 2011; 286:34404.</li>
<li>Murphy RT, Mogensen J, Shaw A, et al. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 2004; 363:371.</li>
<li>Carballo S, Robinson P, Otway R, et al. Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res 2009; 105:375.</li>
<li>Schonberger J, Wang L, Shin JT, et al. Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet 2005; 37:418.</li>
<li>Duboscq-Bidot L, Xu P, Charron P, et al. Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. Cardiovasc Res 2008; 77:118.</li>
<li>Carniel E, Taylor MR, Sinagra G, et al. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 2005; 112:54.</li>
<li>Knoll R, Postel R, Wang J, et al. Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation 2007; 116:515.</li>
<li>Olson TM, Illenberger S, Kishimoto NY, et al. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 2002; 105:431.</li>
<li>Vatta M, Mohapatra B, Jimenez S, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003; 42:2014.</li>
<li>Hayashi T, Arimura T, Itoh-Satoh M, et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 2004; 44:2192.</li>
<li>Mohapatra B, Jimenez S, Lin JH, et al. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab 2003; 80:207.</li>
<li>Inagaki N, Hayashi T, Arimura T, et al. Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun 2006; 342:379.</li>
<li>Bienengraeber M, Olson TM, Selivanov VA, et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 2004; 36:382.</li>
<li>Olson TM, Michels VV, Thibodeau SN, et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998; 280:750.</li>
<li>Mayosi B, Khogali S, Zhang B, Watkins H. Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J Med Genet 1999; 36:796.</li>
<li>Takai E, Akita H, Shiga N, et al. Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy. Am J Med Genet 1999; 86:325.</li>
<li>Tesson F, Sylvius N, Pilotto A, et al. Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy. Eur Heart J 2000; 21:1872.</li>
<li>Zolty R, Brodsky G, Perryman B, et al. Epidemiology of cardiac actin gene mutations in dilated cardiomyopathy. J Cardiac Failure 1999; 5:Supple 1:23.</li>
<li>Taylor MR, Slavov D, Ku L, et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 2007; 115:1244.</li>
<li>Arola AM, Sanchez X, Murphy RT, et al. Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy. Mol Genet Metab 2007; 90:435.</li>
<li>Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000; 106:655.</li>
<li>Karkkainen S, Miettinen R, Tuomainen P, et al. A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy. J Mol Med 2003; 15:15.</li>
<li>Sylvius N, Duboscq-Bidot L, Bouchier C, et al. Mutational analysis of the beta- and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy. Am J Med Genet A 2003; 120A:8.</li>
<li>Li D, Tapscoft T, Gonzalez O, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999; 100:461.</li>
<li>Knoll R, Hoshijima M, Hoffman HM, et al. The Cardiac Mechanical Stretch Sensor Machinery Involves a Z Disc Complex that Is Defective in a Subset of Human Dilated Cardiomyopathy. Cell 2002; 111:943.</li>
<li>Duboscq-Bidot L, Charron P, Ruppert V, et al. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J 2009; 30:2128.</li>
<li>Moulik M, Vatta M, Witt SH, et al. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J Am Coll Cardiol 2009; 54:325.</li>
<li>Hassel D, Dahme T, Erdmann J, et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med 2009; 15:1281.</li>
<li>Purevjav E, Varela J, Morgado M, et al. Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol 2010; 56:1493.</li>
<li>Elliott P, O'Mahony C, Syrris P, et al. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ Cardiovasc Genet 2010; 3:314.</li>
<li>Garcia-Pavia P, Syrris P, Salas C, et al. Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study. Heart 2011; 97:1744.</li>
<li>Marcus FI, Edson S, Towbin JA. Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J Am Coll Cardiol 2013; 61:1945.</li>
<li>Lopez-Ayala JM, Gomez-Milanes I, Sanchez Munoz JJ, et al. Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. Europace 2014; 16:1838.</li>
<li>Rasmussen TB, Hansen J, Nissen PH, et al. Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms. Clin Genet 2013; 84:20.</li>
<li class="">Syrris P, Ward D, Evans A, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 2006; 79:978.</li></ol>Adapted from: Kinnamon DD, Morales A, Bowen DJ, et al. Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study. Circ Cardiovasc Genet 2017; 10:e001826. DOI: <a href="http://circgenetics.ahajournals.org/content/10/6/e001826" target="_blank">10.1161/CIRCGENETICS.117.001826</a>. Copyright © 2017 American Heart Association. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.</div><div id="graphicVersion">Graphic 117134 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
